Cocaine abuse sharply reduced in an effective methadone maintenance program

被引:49
作者
Borg, L
Broe, DM
Ho, A
Kreek, MJ
机构
[1] Rockefeller Univ, Lab Biol Addict Dis, New York, NY 10021 USA
[2] CUNY Herbert H Lehman Coll, Dept Geog & Geol, Bronx, NY 10468 USA
关键词
methadone; cocaine; opioids; hepatitis; HIV;
D O I
10.1300/J069v18n04_06
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
A comprehensive study of an urban methadone clinic with supervised urine analyses for illicit drugs was conducted over an 18 month period for a 133 patient cohort as they entered or remained in methadone maintenance for narcotic addiction. Overall retention during the study was 85%, with significantly (p < .05) higher daily methadone doses (mean 67.1 mg +/- 2.1) in those patients still in treatment at the end of the study. Predictably, illicit opioid use was dramatically reduced, to 10% as measured by urine toxicology in the last month of treatment. Moreover, significantly more patients stopped regular cocaine abuse (69%) than started using cocaine (10%, Fisher's exact test, p = .02). Thus, with effective methadone maintenance using adequate dosages, the majority of patients remain in treatment and reduce cocaine abuse as well as illicit opioid use, with implications for public health by reducing the spread of infectious diseases including hepatitis B, C, D and human immunodeficiency virus (HIV-1).
引用
收藏
页码:63 / 75
页数:13
相关论文
共 42 条
[1]  
Ball J.C., 1991, EFFECTIVENESS METHAD
[2]  
BORG L, 1995, NIDA RES MONOGRAPH S, V153, P17
[3]  
Centers for Disease Control (CDC), 1984, MMWR Morb Mortal Wkly Rep, V33, P377
[4]   COCAINE USE AND HIV INFECTION IN INTRAVENOUS DRUG-USERS IN SAN-FRANCISCO [J].
CHAISSON, RE ;
BACCHETTI, P ;
OSMOND, D ;
BRODIE, B ;
SANDE, MA ;
MOSS, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (04) :561-565
[5]   RESULTS OF THE NIDA TREATMENT DEMONSTRATION GRANTS COCAINE WORKGROUP - CHARACTERISTICS OF COCAINE USERS AND HIV RISK BEHAVIORS [J].
COMPTON, WM ;
LAMB, RJ ;
FLETCHER, BW .
DRUG AND ALCOHOL DEPENDENCE, 1995, 37 (01) :1-6
[6]  
DESJARLAIS DC, 1992, J SUBST ABUSE TREAT, V9, P319
[7]   HIV-1 INFECTION AMONG INTRAVENOUS DRUG-USERS IN MANHATTAN, NEW-YORK-CITY, FROM 1977 THROUGH 1987 [J].
DESJARLAIS, DC ;
FRIEDMAN, SR ;
NOVICK, DM ;
SOTHERAN, JL ;
THOMAS, P ;
YANCOVITZ, SR ;
MILDVAN, D ;
WEBER, J ;
KREEK, MJ ;
MASLANSKY, R ;
BARTELME, S ;
SPIRA, T ;
MARMOR, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (07) :1008-1012
[8]   METHADONE TREATMENT AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME EPIDEMIC [J].
DOLE, VP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (12) :1681-1681
[9]   DO METHADONE PATIENTS SUBSTITUTE OTHER DRUGS FOR HEROIN - PREDICTING SUBSTANCE USE AT 1-YEAR FOLLOW-UP [J].
FAIRBANK, JA ;
DUNTEMAN, GH ;
CONDELLI, WS .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1993, 19 (04) :465-474
[10]  
HANBURY R, 1986, Advances in Alcohol and Substance Abuse, V6, P97